Secretion of cytokines and growth factors as a general cause of constitutive NFkappaB activation in cancer.
about
Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors.HINT1 inhibits beta-catenin/TCF4, USF2 and NFkappaB activity in human hepatoma cellsCritical role of NF-κB in pancreatic cancerRegulation of NF-kappaB by NSD1/FBXL11-dependent reversible lysine methylation of p65.Latent membrane protein 1 regulates STAT1 through NF-kappaB-dependent interferon secretion in Epstein-Barr virus-immortalized B cells.Mutagenesis by reversible promoter insertion to study the activation of NF-kappaB.EGF receptor uses SOS1 to drive constitutive activation of NFκB in cancer cellsQuinacrine overcomes resistance to erlotinib by inhibiting FACT, NF-κB, and cell-cycle progression in non-small cell lung cancerActivation of cAMP-responsive-element-binding protein by PI3 kinase and p38 MAPK is essential for elevated expression of transforming growth factor β2 in cancer cells.NF-kappaB and cancer: how intimate is this relationshipDose-dependent cross-talk between the transforming growth factor-beta and interleukin-1 signaling pathways.CHOP links endoplasmic reticulum stress to NF-κB activation in the pathogenesis of nonalcoholic steatohepatitisTissue factor as an effector of angiogenesis and tumor progression in hematological malignancies.Protein-tyrosine phosphatase 1B expression is induced by inflammation in vivo.A microRNA 221- and 222-mediated feedback loop maintains constitutive activation of NFκB and STAT3 in colorectal cancer cells.Validation-based insertional mutagenesis identifies lysine demethylase FBXL11 as a negative regulator of NFkappaB.Peptides genetically selected for NF-κB activation cooperate with oncogene Ras and model carcinogenic role of inflammation.Use of forward genetics to discover novel regulators of NF-kappaB.The targets of curcumin.Critical role of phosphorylation of serine 165 of YBX1 on the activation of NF-κB in colon cancerNF-κB drives acquired resistance to a novel mutant-selective EGFR inhibitor.Adapting AlphaLISA high throughput screen to discover a novel small-molecule inhibitor targeting protein arginine methyltransferase 5 in pancreatic and colorectal cancers.Hyperactivated NF-{kappa}B and AP-1 transcription factors promote highly accessible chromatin and constitutive transcription across the interleukin-6 gene promoter in metastatic breast cancer cellsMycoplasma infection suppresses p53, activates NF-kappaB and cooperates with oncogenic Ras in rodent fibroblast transformation.PAK5-mediated phosphorylation and nuclear translocation of NF-κB-p65 promotes breast cancer cell proliferation in vitro and in vivo.HDAC6 promotes hepatocellular carcinoma progression by inhibiting P53 transcriptional activity.FGF5 is expressed in melanoma and enhances malignancy in vitro and in vivo.My life in science, not the restaurant business.STAT3 activation in endothelial cells is important for tumor metastasis via increased cell adhesion molecule expression.Cardiac fibroblasts influence cardiomyocyte phenotype in vitro.
P2860
Q24312920-C920F88A-0B76-4F69-B880-E02FF3342B05Q24645174-C17796FE-E80D-48F6-B017-A554312AE1D0Q26864198-C9212F3D-A055-42B8-92E4-F48800D66912Q33591456-63D83A89-FEB9-4F5D-A992-E4F15054F50EQ33724152-EF72A9F1-7C1A-4FCC-A2FB-569E5724732AQ33772184-534C593B-BC43-4AEA-A2F5-CDD55750CCCDQ34060669-61F5E963-7FFD-4042-9C54-C0E9713E94D6Q34143354-724C8523-5BDD-4702-BCBD-350E51F6C478Q34238220-25F19B8C-B718-48CC-BF2F-27360301C6A0Q35143597-CF34EAA8-3DF4-4A17-8413-AAD99F5EFF6BQ35663498-F8B3576D-EAA8-4073-83C1-69388605520DQ35717788-A4FF6903-600D-46C9-A516-53058CA9E1E1Q36490167-AF5E798F-29EB-4C81-8FB8-FFD25D7961BAQ36662772-357C00CD-8DEF-4ABA-B577-5FA1FEED8D3DQ36823003-0A16F406-0DFF-46B7-BC50-6762DB5E7112Q37329024-B8744A31-E449-4C6D-9C05-9CC305360E26Q37543936-36F51FCF-9AD3-4A25-A3BE-DC87150036E9Q37762070-A6324B7A-0B2C-42B9-AD6A-90F976B7D8B0Q37800949-EA338C7C-415A-45E2-9279-638FBC8AC624Q38286076-A7D6071C-1672-4DFA-959A-90418A5AE6A1Q38631853-60FA8324-0DD5-4000-8048-E08DE25949ECQ38673638-2F6A00A3-595D-4008-8DEC-4BA81F30A80BQ39811482-3327D8F9-A931-445C-9CA7-AFF598B7316BQ39992406-934C33EE-F8FC-41FB-A84F-56A8CC15F50DQ42587906-3DBE2FCF-B862-429D-9125-1ACF74D3D1CBQ44938727-F239FF18-3FD1-449C-B918-F0ED39FE7AA4Q47160915-7D3D4C91-3E68-4199-BEB3-B69DB9841367Q48638941-C1101291-2F0C-4895-B9D8-0BA9FF139EE7Q50986576-33FBF5D7-983E-471D-A167-FFFD44BBDDF1Q51083125-2CA40627-E800-4B7C-996C-0309B7C55CF0
P2860
Secretion of cytokines and growth factors as a general cause of constitutive NFkappaB activation in cancer.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Secretion of cytokines and gro ...... NFkappaB activation in cancer.
@en
type
label
Secretion of cytokines and gro ...... NFkappaB activation in cancer.
@en
prefLabel
Secretion of cytokines and gro ...... NFkappaB activation in cancer.
@en
P2093
P2860
P356
P1433
P1476
Secretion of cytokines and gro ...... NFkappaB activation in cancer.
@en
P2093
Chetan V Hampole
George R Stark
Shannon M Swiatkowski
Swati S Sathe
P2860
P2888
P304
P356
10.1038/SJ.ONC.1207332
P407
P577
2004-03-01T00:00:00Z
P5875
P6179
1030617849